Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States

OBJECTIVE: To understand factors guiding overactive bladder (OAB) therapy selection and experience with combination therapy (antimuscarinics and beta-3 agonists). METHODS: Cross-sectional surveys of OAB patients and OAB-treating physicians in the USA were conducted. Patients receiving monotherapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraus, Stephen R., Li, Junlong, Kristy, Rita M., Lockefeer, Amy, Yang, Hongbo, Zhou, Mo, Walker, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127871/
https://www.ncbi.nlm.nih.gov/pubmed/35588263
http://dx.doi.org/10.1177/03000605221098176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127871/
https://www.ncbi.nlm.nih.gov/pubmed/35588263
http://dx.doi.org/10.1177/03000605221098176

Ejemplares similares